University of Pennsylvania Abramson Cancer Center: Clinical Trials & Research Profile
Academic Medical Center in Philadelphia, PA · Primary Specialty: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Clinical Trial Research Site |
| Institutional Sector & Location | Academic Medical Center (Philadelphia, PA) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 491 active (245 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 899 |
| Completed vs Early-Stopped Studies | 264 completed / 134 stopped (14.9% stop rate) |
| Median Closed Enrollment | 127 participants |
| Median Completed Study Duration | 1,128 calendar days |
| Physical Hospital Site Disclosure | 100.0% named hospital campus |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Penn Medicine (University of Pennsylvania) across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk